Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 20/20 | 0.64 |
| ▸ | CTSD | P07339 | 10/20 | 0.64 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15510341 | 0.99 | BACE1 (0.63) | BACE1CTSDKCNH2 | |
| SCHEMBL15509727 | 0.98 | BACE1 (0.64) | BACE1CTSDKCNH2 | |
| SCHEMBL15510021 | 0.93 | BACE1 (0.75) | BACE1CTSDKCNH2 | |
| SCHEMBL14877681 | 0.92 | BACE1 (0.62) | BACE1CTSDKCNH2 | |
| SCHEMBL15509746 | 0.92 | BACE1 (0.62) | BACE1CTSDKCNH2 | |
| SCHEMBL15509999 | 0.91 | BACE1 (0.61) | BACE1CTSDKCNH2 | |
| SCHEMBL2382324 | 0.91 | BACE1 (0.77) | BACE1CTSDKCNH2 | |
| SCHEMBL15510064 | 0.91 | BACE1 (0.62) | BACE1CTSDKCNH2 | |
| SCHEMBL15510615 | 0.90 | BACE1 (0.63) | BACE1CTSDKCNH2 | |
| SCHEMBL2517615 | 0.88 | BACE1 (0.77) | BACE1CTSDKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2328903-B1 | SPIRO-TETRACYCLIC RING COMPOUNDS AS BETASECRETASE MODULATORS AND METHODS OF USE | AMGEN INC (US) | 2014-03-05 | — | — | EP | disclosed |
| US-8426447-B2 | Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use | AMGEN INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-8426447-B2 | Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use | AMGEN INC. (US) | 2013-04-23 | — | — | US | disclosed |